Article in Molecular biology and evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Jeffrey A HaltomBioinformatics and Computational Biology Program, Genetics Program, Iowa State University, Ames, IA 50011, USA.ORCID 0000-0003-4534-2920
Nidia S TrovaoCOVID-19 International Research Team, Medford, MA 02155, USA.ORCID 0000-0002-2106-1166
Joseph W GuarnieriCOVID-19 International Research Team, Medford, MA 02155, USA.
Vincent PanDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.
Urminder SinghBioinformatics and Computational Biology Program, Genetics Program, Iowa State University, Ames, IA 50011, USA.
Sergey TsoyDivision of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Collin A O'LearyRoy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50011, USA.ORCID 0000-0002-4246-6277
Yaron BramDivision of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0001-9711-575X
Gabrielle A WidjajaCenter for Mitochondrial and Epigenomic Medicine, Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Zimu CenCenter for Mitochondrial and Epigenomic Medicine, Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Robert MellerDepartment of Neurobiology, Morehouse School of Medicine, Atlanta, GA 30310-1495, USA.
Stephen B BaylinDepartment of Neurobiology, Morehouse School of Medicine, Atlanta, GA 30310-1495, USA.ORCID 0000-0003-3697-3798
Walter N MossBioinformatics and Computational Biology Program, Genetics Program, Iowa State University, Ames, IA 50011, USA.ORCID 0000-0001-6419-5570
Basil J NikolauBioinformatics and Computational Biology Program, Genetics Program, Iowa State University, Ames, IA 50011, USA.ORCID 0000-0002-4672-7139
Francisco J EnguitaVan Andel Research Institute, Grand Rapids, MI 49503, USA.ORCID 0000-0002-8072-8557
Douglas C WallaceCenter for Mitochondrial and Epigenomic Medicine, Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-7480-8278
Afshin BeheshtiCOVID-19 International Research Team, Medford, MA 02155, USA.ORCID 0000-0003-4643-531X
Robert E SchwartzDivision of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-5417-5995
Eve Syrkin WurteleBioinformatics and Computational Biology Program, Genetics Program, Iowa State University, Ames, IA 50011, USA.ORCID 0000-0003-1552-9495
Funding
Genetic Viral and Host Adaptations to Breach Species Barriers of HCVR01AI107301 · NIAID · PRINCETON UNIVERSITY · PI Thomas Pietschmann, Alexander Ploss · 2013 to 2026
$6.0M
Finding, folding and characterizing the functions of disease-relevant RNA structuresR01GM133810 · NIGMS · IOWA STATE UNIVERSITY · PI Walter Moss · 2019 to 2026
$2.8M
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyteR01DK121072 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHWARTZ, ROBERT E · 2020 to 2024
$2.6M
Bill & Melinda Gates Foundation INV-046722DOD W81XWH-21-1-0128National Science Foundation ACI-1548562NIAID NIH HHS R01 AI107301NIDDK NIH HHS R01 DK121072NIGMS NIH HHS R01 GM133810NIH HHS NIAID 2R01AI107301NIH HHS NIDDK R01DK121072NIH/NIGMS R01GM133810
6 · The paper itself
Abstract
Orphan genes, which encode species-specific proteins, are common but are rarely investigated. The SARS-CoV-2 orphan gene, ORF10, has been understudied; in vitro work suggests it may modulate innate immunity. Whether ORF10 influences COVID-19 outcomes in humans remained unknown. Here, analyzing millions of SARS-CoV-2 genomes, we find ORF10 sequences are identical to ancestral Wuhan-Hu-1 haplotype. In all variants of concern, <5% of genomes carry any ORF10 mutation. Despite limited statistical power due to the sparsity of mutated sequences, four ORF10 mutations were associated with less severe clinical outcomes in COVID-19 patients: three affect protein structure, one alters RNA structural dynamics. No mutations were linked to increased severity. ORF10 transcript levels in humans and human models are conditionally discordant from other SARS-CoV-2 genes. ORF10 expression in A549 and 293T cells significantly perturbs oxidative phosphorylation gene expression, disrupts immune gene networks, and shifts expression of 14 novel human transcripts. ORF10 is present in multiple Betacoronavirus pandemicum strains, but absent from SARS-CoV-1-like strains. We propose that this strain-restricted orphan gene contributes to severe COVID-19 in humans, with implications for future therapeutic strategies. These findings underscore the importance of studying recently evolved, potentially overlooked, viral orphan genes as a standard approach in pandemic preparedness.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Importance of De Novo Gene Evolution to Emerging Viral Threats: The ORF10 Strain-Restricted Orphan Gene of SARS-CoV-2 Promotes Pathogenesis. · full record | OpenQuestion